Antisense lncrna pcna as1 promotes esophageal squamous cell carcinoma progression through the mir 3p/pcna axis

HIGHLIGHTS

  • who: Tao Hu et al. from the Sixty specimen pairs of tumor and non-tumor tissues were obtained from ESCC surgery patients at the Fourth Hospital of Hebei Medical University from , to , (Table, )These ESCC patients did not undergo chemotherapy or radiotherapy treatments before the operation. All ESCC tissue specimens were confirmed by HE staining, and no cancerous invasion was detected in the normal tissues. The ethics committee endorsed this study, and all patients who provided clinical samples signed an informed consent form. have published the research: Antisense lncRNA PCNA AS1 promotes esophageal squamous cell carcinoma progression . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?